CeQur raises $120M to support insulin delivery tech
January 7, 2025
Insulin delivery technology developer CeQur today announced a significant funding round to support its commercialization efforts.
Insulin delivery technology developer CeQur today announced a significant funding round to support its commercialization efforts.
Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure management system.
Medtronic (NYSE: MDT)+
today announced CE mark approval for its Harmony transcatheter pulmonary valve (TPV) system
IceCure Medical (Nasdaq:ICCM) announced today that it received an intention to grant notice from the European Patent Office.
Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and distorted objects. Dry AMD accounts for 90% of all AMD cases, with relatively mild vision impairment; however, approximately 30% progress to the severe vision loss associated with wet AMD within 10 years.
Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.
MannKind today announced six-month results from its Phase 3 INHALE-1 study of Afrezza insulin inhalation powder in children.
MILPITAS, Calif., Dec. 5, 2024 /PRNewswire/ — LifeSignals, Inc. today announced that the UbiqVue 2A Multiparameter System has received EU MDR Certification, marking another significant milestone in deploying continuous wireless patient monitoring for population health management following FDA 510(k) Clearance last month.
GE HealthCare (Nasdaq:GEHC) today announced its new Pristina Via mammography system designed to enhance the screening experience.
Align Technology (Nasdaq:ALGN) announced today that it received CE mark for its Invisalign palatal expander system.